Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/125949
Title: The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation
Author: Schneider, Taiane
Martinez-Martinez, Arturo
Cubillos Rojas, Mónica
Bartrons Bach, Ramon
Ventura Pujol, Francesc
Rosa López, José Luis
Keywords: Ubiqüitina
Proteïnes de membrana
Transducció de senyal cel·lular
Regulació cel·lular
Ubiquitin
Membrane proteins
Cellular signal transduction
Cellular control mechanisms
Issue Date: 31-Jul-2018
Publisher: Impact Journals
Abstract: The RAF/MEK/ERK cascade is a conserved intracellular signaling pathway that controls fundamental cellular processes including growth, proliferation, differentiation, survival and migration. Aberrant regulation of this signaling pathway has long been associated with human cancers. A major point of regulation of this pathway occurs at the level of the serine/threonine protein kinase C-RAF. Here, we show how the E3 ubiquitin ligase HERC1 regulates ERK signaling. HERC1 knockdown induced cellular proliferation, which is associated with an increase in ERK phosphorylation and in C-RAF protein levels. We demonstrate that overexpression of wild-type C-RAF is sufficient to increase ERK phosphorylation. Experiments with pharmacological inhibitors of RAF activity, or with interference RNA, show that the regulation of ERK phosphorylation by HERC1 is RAF-dependent. Immunoprecipitation, pull-down and confocal fluorescence microscopy experiments demonstrate an interaction between HERC1 and C-RAF proteins. Mechanistically, HERC1 controls C-RAF stability by regulating its polyubiquitylation in a lysine 48-linked chain. In vitro ubiquitylation assays indicate that C-RAF is a substrate of the E3 ubiquitin ligase HERC1. Altogether, we show how HERC1 can regulate cell proliferation through the activation of ERK signaling by a mechanism that affects C-RAF's stability.
Note: Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.25847
It is part of: Oncotarget, 2018, vol. 9, num. 59, p. 31531-31548
URI: https://hdl.handle.net/2445/125949
Related resource: https://doi.org/10.18632/oncotarget.25847
ISSN: 1949-2553
Appears in Collections:Articles publicats en revistes (Ciències Fisiològiques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
681514.pdf6.45 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons